C
Cathworks
Medical technology company focused transforming how cardiovascular disease is diagnosed and treated
About Cathworks
CathWorks is a medical technology startup that operates in the healthcare sector, specifically in the field of interventional cardiology. The company has developed a groundbreaking system called the FFRangio System, which uses artificial intelligence and advanced computational science to provide detailed physiological information from routine angiograms. This information is crucial for cardiologists in making informed treatment decisions for their patients.
The FFRangio System is designed to serve interventional cardiologists and their patients, providing a more comprehensive view of the patient's physiology. This system has shown excellent diagnostic performance compared to traditional invasive FFR wires, making it a potential new standard of care in physiology assessment.
CathWorks' business model revolves around the development, marketing, and sale of the FFRangio System to hospitals and clinics. The company generates revenue through the sale of this system, which is used in cath labs by cardiologists. The system's ability to provide more accurate and detailed information can lead to better patient outcomes, making it a valuable tool for healthcare providers.
In conclusion, CathWorks is a promising startup in the medical technology field, offering a novel solution that can significantly improve the diagnosis and treatment process in interventional cardiology. The company's FFRangio System has the potential to become a new standard in the field, providing a more comprehensive view of patients' physiology and leading to better treatment decisions.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2013
- Headquarters
- Kfar Saba, Israel
- Employees
- 81
- Open positions
- 1
- Dealroom signal
- 75.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Cardiology and cardiovascular, Catheters, Non-Invasive medical devices and treatments, Tech for Hospitals and Clinics, Clinical Decision Support, Hard Tech, DT and LS
- Technology
- Hardware, 3D Technology, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Apr 2026 | $585M | $585M | Medtronic | ↗ |
| LATE VCOther financing | Jul 2022 | $75M | $300M | Medtronic | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Cathworks is 3.6K monthly website visits, down 29.4% over the last three months. Cathworks's team grew 3.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
TriVentures
Quark Venture
Corundum Open Innovations
BioStar Capital
Pontifax Funds
Planven Investments
Series B and later2 investors entered at this stage
Deerfield
Medtronic
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cathworks on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cathworks’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.